Michael King

Michael King is an accomplished financial executive and advisor with a robust track record in the biotechnology sector. Currently serving as Chief Financial Officer at Scipher Medicine since 2024, King bolsters organizational financial management in a company that utilizes AI for patient therapy matching in autoimmune diseases. In addition, King holds multiple leadership roles, including Board Member at Regio Biosciences, which is focused on advancing treatments for cardio-metabolic diseases and cancers, and Co-Founder of The BioForge Group, a biotechnology advisory firm. Previous experiences include CFO-Advisor positions at Black Canyon Bio and Primera Therapeutics, as well as Chief Financial Officer at Mayflower Bioventures, among other roles. King possesses a Master of Business Administration from Columbia Business School and a Bachelor of Arts from Wesleyan University.